{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:26:03Z","timestamp":1788344763877,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s11934-006-0060-7","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T14:46:09Z","timestamp":1181227569000},"page":"490-496","source":"Crossref","is-referenced-by-count":18,"title":["Erectile dysfunction and cardiac disease: Recommendations of the second princeton conference"],"prefix":"10.1007","volume":"7","author":[{"given":"Raymond C.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Kostis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","volume":"151","author":"HA Feldman","year":"1994","unstructured":"Feldman HA, Goldstein I, Hatzichristou DG, et al.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151:54\u201361.","journal-title":"J Urol"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00006842-199807000-00011","volume":"60","author":"AB Araujo","year":"1998","unstructured":"Araujo AB, Durante R, Feldman HA, et al.: The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998, 60:458\u2013465.","journal-title":"Psychosom Med"},{"key":"60_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1185\/030079904125003467","volume":"20","author":"RC Rosen","year":"2004","unstructured":"Rosen RC, Fisher W, Eardley I, et al.: The Multinational Men\u2019s Attitudes to Life Events and Sexuality (MALES) study: prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004, 20:607\u2013617.","journal-title":"Curr Med Res Opin"},{"key":"60_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ucl.2005.08.004","volume":"32","author":"RC Rosen","year":"2005","unstructured":"Rosen RC, Wing R, Schneider S, Gendrano N 3rd:Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am 2005, 32:403\u2013417. A comprehensive, recent review of prevalence and risk factors for ED with special emphasis on the role of major comborbidities (eg, diabetes, heart disease, depression).","journal-title":"Urol Clin North Am"},{"key":"60_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0090-4295(98)00292-1","volume":"52","author":"R Shabsigh","year":"1998","unstructured":"Shabsigh R, Klein LT, Seidman S, et al.: Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998, 52:848\u2013852.","journal-title":"Urology"},{"key":"60_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1006\/pmed.2000.0643","volume":"30","author":"HA Feldman","year":"2000","unstructured":"Feldman HA, Johannes CB, Derby CA, et al.: Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000, 30:328\u2013338.","journal-title":"Prev Med"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-139-3-200308050-00005","volume":"139","author":"CG Bacon","year":"2003","unstructured":"Bacon CG, Mittleman MA, Kawachi I, et al.: Sexual function in men older than 50 years of age: results from the Health Professionals Follow-Up Study. Ann Intern Med 2003, 139:161\u2013168.","journal-title":"Ann Intern Med"},{"key":"60_CR8","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jacc.2003.11.041","volume":"43","author":"MM Fung","year":"2004","unstructured":"Fung MM, Bettencourt R, Barrett-Connor E: Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 2004, 43:1405\u20131411.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(05)66911-5","volume":"366","author":"CA Holden","year":"2005","unstructured":"Holden CA, McLachlan RI, Pitts M, et al.: Men in Australia, Telephone Survey (MATeS) I: a national survey of the reproductive health and concerns of middle aged and older Australian men. Lancet 2005, 366:218\u2013224.","journal-title":"Lancet"},{"key":"60_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ijir.3901333","volume":"17","author":"K Esposito","year":"2005","unstructured":"Esposito K, Giugliano D: Obesity, the metabolic syndrome and sexual dysfunction. Int J Impot Res 2005, 17:391\u2013398.","journal-title":"Int J Impot Res"},{"issue":"Suppl 4","key":"60_CR11","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/sj.ijir.3900567","volume":"12","author":"JB McKinlay","year":"2000","unstructured":"McKinlay JB: The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000, 12(Suppl 4):S6-S11.","journal-title":"Int J Impot Res"},{"key":"60_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1743-6109.2004.04023.x","volume":"1","author":"W Fisher","year":"2004","unstructured":"Fisher W, Rosen RC, Eardley I, et al.: The multinational men\u2019s attitudes to life events and sexuality (MALES) study phase II: understanding PDE5 inhibitor treatment seeking patterns among men with erectile dysfunction. J Sex Med 2004, 1:150\u2013160.","journal-title":"J Sex Med"},{"key":"60_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-9149(00)00896-1","volume":"86","author":"R DeBusk","year":"2000","unstructured":"DeBusk R, Drory Y, Goldstein I, et al.: Management of sexual dysfunction in patients with cardiovascular disease; the Princeton Consensus Panel. Am J Cardiol 2000, 86:175\u2013181.","journal-title":"Am J Cardiol"},{"key":"60_CR14","doi-asserted-by":"publisher","first-page":"9M","DOI":"10.1016\/S0002-9149(03)00824-5","volume":"92","author":"RC Rosen","year":"2003","unstructured":"Rosen RC, Kostis JB: Overview of phosphodiesterase 5 inhibition in erectile dysfunction. Am J Cardiol 2003, 92:9M-18M.","journal-title":"Am J Cardiol"},{"key":"60_CR15","first-page":"1371","volume":"22","author":"RA Kloner","year":"2002","unstructured":"Kloner RA, Mohan P, Norenberg C: Cardiovascular safety of vardenafil, a potent, highly selective PDE5 inhibitor in patients with erectile dysfunction: analysis of five controlled clinical trials. Pharmacol Ther 2002, 22:1371.","journal-title":"Pharmacol Ther"},{"key":"60_CR16","doi-asserted-by":"publisher","first-page":"37M","DOI":"10.1016\/S0002-9149(03)00074-2","volume":"92","author":"RA Kloner","year":"2003","unstructured":"Kloner RA, Mitchell M, Emmick JT: Cardiovascular effects of tadalafil. Am J Cardiol 2003, 92(Suppl):37M-46M.","journal-title":"Am J Cardiol"},{"key":"60_CR17","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1001\/jama.291.24.2978","volume":"291","author":"K Esposito","year":"2004","unstructured":"Esposito K, Giugliano F, Di Palo C, et al.: Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004, 291:2978\u20132984. The benefits of lifestyle intervention (weight loss and exercise) in the management of ED were shown in this randomized, controlled trial of men with moderate obesity and ED.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"60_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.amjcard.2005.10.011","volume":"12","author":"R Rosen","year":"2005","unstructured":"Rosen R, Friedman M, Kostis JB:Lifestyle management of erectile dysfunction: the role of cardiovascular and concomitant risk factors. Am J Cardiol 2005, 12(Suppl 2):76\u201379. The role of lifestyle factors in the management of ED are considered in-depth in this article.","journal-title":"Am J Cardiol"},{"key":"60_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.amjcard.2005.03.065","volume":"96","author":"JB Kostis","year":"2005","unstructured":"Kostis JB, Jackson G, Rosen R: Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005, 96:313\u2013321. Findings and recommendations of the Second Princeton Consensus on sexual dysfunction and cardiac risk are presented in this article. A revised algorithm for evaluation of cardiac risk associated with sexual activity is presented.","journal-title":"Am J Cardiol"},{"key":"60_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1742-1241.2006.00843a.x","volume":"60","author":"G Jackson","year":"2006","unstructured":"Jackson G, The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines, new challenges. Int J Clin Pract 2006, 60:127.","journal-title":"Int J Clin Pract"},{"key":"60_CR21","doi-asserted-by":"publisher","first-page":"8M","DOI":"10.1016\/j.amjcard.2005.07.004","volume":"96","author":"P Ganz","year":"2005","unstructured":"Ganz P: Erectile dysfunction: pathophysiological mechanisms pointing to underlying cardiovascular disease. Am J Cardiol 2005, 96:8M-12M.","journal-title":"Am J Cardiol"},{"key":"60_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/heart.89.3.251","volume":"89","author":"H Solomon","year":"2003","unstructured":"Solomon H, Man JW, Jackson G: Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003, 89:251\u2013253.","journal-title":"Heart"},{"key":"60_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1742-1241.2005.00453.x","volume":"59","author":"M Kirby","year":"2005","unstructured":"Kirby M, Jackson G, Simonsen U: Endothelial dysfunction links erectile dysfunction to heart disease? Int J Clin Pract 2005, 59:225\u2013229.","journal-title":"Int J Clin Pract"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1527-5299.2002.00288.x","volume":"9","author":"S Katz","year":"2003","unstructured":"Katz S: Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure. Congest Heart Fail 2003, 9:9\u201315. PDE5 inhibitors can be used in the treatment of other cardiovascular conditions. This article describes the results of a controlled trial of sildenafil in the treatment of congestive heart failure.","journal-title":"Congest Heart Fail"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1742-1241.2002.tb11281.x","volume":"56","author":"G Jackson","year":"2002","unstructured":"Jackson G, Chambers J: Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit. Int J Clin Pact 2002, 56:397\u2013398.","journal-title":"Int J Clin Pact"},{"key":"60_CR26","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"TF Lue","year":"2000","unstructured":"Lue TF: Erectile dysfunction. N Engl J Med 2000, 342:1802\u20131813.","journal-title":"N Engl J Med"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1152\/physrev.1995.75.1.191","volume":"75","author":"KE Andersson","year":"1995","unstructured":"Andersson KE, Wagner G: Physiology of penile erection. Physiol Rev 1995, 75:191\u2013236.","journal-title":"Physiol Rev"},{"key":"60_CR28","doi-asserted-by":"publisher","first-page":"13M","DOI":"10.1016\/j.amjcard.2005.07.005","volume":"96","author":"V Fonseca","year":"2005","unstructured":"Fonseca V, Jawa A: Endothelial\/erectile dysfunction in diabetes and the metabolic syndrome: Implications for cardiovascular disease and patient management. Am J Cardiol 2005, 96:13M-18M.","journal-title":"Am J Cardiol"},{"key":"60_CR29","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1001\/jama.294.23.2996","volume":"294","author":"IM Thompson","year":"2005","unstructured":"Thompson IM, Tangen CM, Goodman PJ, et al.: Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005, 294:2996\u20133002. This widely-cited study demonstrated a strong link between ED and subsequent cardiovascular events among participants in the Prostate Prevention Trial.","journal-title":"JAMA"},{"key":"60_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1001\/archinte.166.2.207","volume":"166","author":"CS Saigal","year":"2006","unstructured":"Saigal CS, Wessells H, Pace J, et al.: Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006, 166:207\u2013212.","journal-title":"Arch Intern Med"},{"key":"60_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/archinte.166.2.213","volume":"166","author":"SA Grover","year":"2006","unstructured":"Grover SA, Lowensteyn I, Kaouache M, et al.: The prevalence of erectile dysfunction in the primary care setting. Arch Intern Med 2006, 166:213\u2013219.","journal-title":"Arch Intern Med"},{"key":"60_CR32","doi-asserted-by":"publisher","first-page":"19M","DOI":"10.1016\/j.amjcard.2005.07.006","volume":"96","author":"P Montorsi","year":"2005","unstructured":"Montorsi P, Ravagnani PM, Galli S, et al.: The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005, 96:19M-23M.","journal-title":"Am J Cardiol"},{"key":"60_CR33","doi-asserted-by":"publisher","first-page":"47M","DOI":"10.1016\/j.amjcard.2005.10.005","volume":"96","author":"MD Patel","year":"2005","unstructured":"Patel MD, Katz SD: Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension. Am J Cardiol 2005, 96:47M-51M.","journal-title":"Am J Cardiol"},{"key":"60_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/01.ju.0000132389.97804.d7","volume":"172","author":"R Shabsigh","year":"2004","unstructured":"Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H:Randomized study of testosterone gel as adjunctive therapy to Sildenafil in hypogonadal men with erectile dysfunction who do not respond to Sildenafil alone. J Urol 2004, 172:658\u2013663.","journal-title":"J Urol"},{"key":"60_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/tam.6.1.1.7","volume":"6","author":"MA Boyanov","year":"2003","unstructured":"Boyanov MA, Boneva Z, Christov VG: Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003, 6:1\u20137.","journal-title":"Aging Male"},{"key":"60_CR36","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1210\/jc.85.8.2839","volume":"85","author":"C Wang","year":"2000","unstructured":"Wang C, Swerdloff RS, Iranmanesh A, et al.: Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000, 85:2839\u20132853.","journal-title":"J Clin Endocrinol Metab"},{"key":"60_CR37","doi-asserted-by":"publisher","first-page":"67M","DOI":"10.1016\/j.amjcard.2005.10.009","volume":"96","author":"R Shabsigh","year":"2005","unstructured":"Shabsigh R, Katz M, Yan G, Makhsida N: Cardiovascular issues in hypogonadism and testosterone therapy. Am J Cardiol 2005, 96:67M-72M. This article reviews the cardiac safety and potential benefits of testosterone replacement therapy in the treatment of hypogonadism.","journal-title":"Am J Cardiol"},{"key":"60_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ijir.3901010","volume":"15","author":"A Nicolosi","year":"2003","unstructured":"Nicolosi A, Glasser DB, Moreira ED, Villa M: Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res 2003, 15:253\u2013257.","journal-title":"Int J Impot Res"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-006-0060-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0060-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:44:33Z","timestamp":1683877473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-006-0060-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11934-006-0060-7","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}